Celltrion begins phase 1 human trial of COVID-19 antiviral antibody candidate
Celltrion Group, a South Korean pharma company, has launched a phase 1 human clinical trial of a potential antiviral antibody treatment for COVID-19 patients. The in-human study of the COVID-19 antiviral antibody comes in the wake of the positive results delivered by it in pre-clinical studies and the following approval of the investigational new drug […]